India's Onesource Specialty Pharma rises most in 2-1/2 months on quarterly profit
27/07/2026 07:43
BUZZ-India's Onesource Specialty Pharma rises most in 2-1/2 months on quarterly profit ** Shares of India's Onesource Specialty Pharma ONEO.NS rise 3.6% to 1,713.30 rupees, their biggest intraday percentage gain since May 7
** The specialty pharmaceutical contract development and manufacturing company reports June-quarter consol profit of 250 million rupees ($2.60 million) versus a loss of 1.86 million rupees a year earlier
** Consol revenue from operations rises 37.3% Y/Y in the quarter
** Investec says June-quarter sales up 37% and EBITDA up 39%, driven by semaglutide commercialisation, new MSA contracts and customer additions
** Brokerage says company's capacity is set to double by FY27
** Onesource stock down 5.4%, YTD
($1 = 96.1900 Indian rupees)
(Reporting by Payel Das in Bengaluru)
Recent news on Onesource Specialty Pharma
See all newsIndia's Onesource Specialty Pharma rises most in 2-1/2 months on quarterly profit
Brief: Onesource Specialty Pharma June-Quarter Consol PAT 250 Million Rupees
Brief: Onesource Specialty Pharma Says Co, Formycon AG Announce Strategic Manufacturing Partnership For Biosimilars
Brief: Onesource Specialty Pharma Says Delay In Dr Reddy's Supplies Does Not Materially Impact Co's Operations
Brief: Onesource Specialty Pharma Says USFDA Conducts Routine CGMP Inspection At Onesource SPD Bengaluru